Support our amazing very senior "Junior Drs" on the picket line 🥰

JUNIOR DOCTOR - PAY EXPLAINED 2008 - 24 Tins of beans an hour 2023 - 10 Tins of beans an hour #PayRestoration

Great stuff. HES linkage to trial data. The possibilities are endless!

New Competition. RT and follow (if you haven't already) to win this 12 x 8 inch Canning Dock, #Liverpool at Dawn print. The draw will be on Sunday, 21st May 2023.

📢📢📢 CALLING ONCOLOGY COLLEAGUES 👀 Clinical Fellowship Opportunities to support the National Kidney Cancer Audit More info: Kidney Cancer fellow: ow.ly/EKW050OFGeh NATCAN clinical fellows - ow.ly/5KKg50OFGef DEADLINE: 25 June Jon Aning Grant Stewart

Radical Tx of CPG1 (low risk) 38% in 🇺🇸 vs 14% in 🏴󠁧󠁢󠁥󠁮󠁧󠁿 - I don't think the problem is what you call it but where your managed😏 - Comparison of the treatment of men with prostate cancer between the US and England: an international population-bas… pubmed.ncbi.nlm.nih.gov/35001083/

Any urology trainee with a sub-specialty interest in kidney cancer should definitely apply! Access to huge national datasets with opportunities for MD/PhD in surgical outcomes research. Data ready to be analysed with scope for big output (if the National Prostate Cancer Audit is anything to go by)!

Sarah is The Poet who Spells Her Name. Dr Liz O'Riordan NHS England Gender disparity persists in the UK surgical workforce and there are significant differences between surgical specialties esp' Vascular Surgery, Cardiothoracic Surgery, Neurosurgery & Trauma and Orthopaedics. bmjopen.bmj.com/content/12/2/e… via Matt Parry et al

Andrew Castle commentating on Wimbledon reminds me of this excellent caption.

Routine data 🤩

💡 Collecting RCT data can be expensive and time-consuming. What if there's a more efficient way? Learn how routine hospital administrative data can revolutionise clinical trials bit.ly/3pTPq3z Matt Sydes Nick James also on @Prof-Nick-James.bsky.social OncoAlert Dr Hattie Mintz

Michael Rowe Hello Michael. Thank you very much! Really pleased you found it informative. This really is a data goldmine, the future!

📢 Exciting times at NATCAN as we welcome our new Clinical Director, Dr Ajay Aggarwal. Take a look at the full announcement on our website 📢 #NATCAN bit.ly/45XuSH7 Ajay Aggarwal London School of Hygiene & Tropical Medicine Healthcare Quality Improvement Partnership NHS England

Delighted to have been appointed Clinical Director of the National Cancer Audits in England and Wales. I look forward to working with clinical, policy and patient communities to drive improvements in the quality and experience of cancer care across the nine cancers.

Delighted to announce a clinical fellowship in radiorecurrent prostate cancer at UCL/UCLH with Susan Heavey John Withington in UCL Div of Surgery! PhD funding included & opportunity to develop some very exciting work! Suitable for urologists and oncologists ucl.ac.uk/work-at-ucl/se…

The National Prostate Cancer Audit's investigation of the organisation & delivery of supportive services for patients with prostate cancer in the NHS in England and Wales is in BMJ_Open. Joanna Dodkins @JanvanderMeule6 Ajay Aggarwal GU Cancer Research group bmjopen.bmj.com/content/13/11/…

We are excited to welcome Dr Alison Tree to the National Prostate Cancer Audit as the Clinical Lead for Oncology. Alison joins us from The Royal Marsden NHS Foundation Trust where she is a Consultant clinical oncologist. You can follow Alison on Alison Tree 💙

Ash Paul Ashwin Sridhar Hashim U. Ahmed Jesse Luke 🧠💊 Prostate Cancer UK Ella Pickover Susan Bewley Michael Baum Steven Laitner Paul Pharoah (R soul) 🇪🇺🇵🇬🇿🇦🇬🇧 Naser Turabi René Wittmer Guylene Theriault Roland Grad Imperial College London Professor Azeem Majeed Muir Gray Emmerdale Sidney Kimmel Comprehensive Cancer Center JAMA Network Daniel Lin, MD Have the US finally caught up then ? nature.com/articles/s4139…

'Treatment rates of prostate cancer were higher in the US compared to England raising potential over-treatment concerns for low-risk disease (CPG1) in the US and under-treatment of clinically significant disease (CPG3-5) in England', via Matt Parry et al